Mayne Pharma Group (MAYNF) Stock Price, News & Analysis

Company Overview

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: International Branded Products, and Portfolio Product Division. It provides oral drug delivery systems; and contract development and manufacturing services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.

Key Stats

• Today's Range: $2.85 to $2.85
• 50-Day Range: $2.85 to $4.59
• 52-Week Range: $2.42 to $4.60
• Volume: 300 shs
• Average Volume: 1,829 shs
• Market Capitalization: N/A
• P/E Ratio: 79.17
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Mayne Pharma Group Stock Analysis - MarketRank™

Mayne Pharma Group scored higher than 0% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Mayne Pharma Group.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Mayne Pharma Group is 79.17, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.79.

Price to Earnings Ratio vs. Sector

The P/E ratio of Mayne Pharma Group is 79.17, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.72.

Short Interest

• Score: 0.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Mayne Pharma Group has a short interest ratio ("days to cover") of 71.6, which indicates bearish sentiment.

Change versus previous month

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Mayne Pharma Group does not currently pay a dividend.

Dividend Growth

Mayne Pharma Group does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Mayne Pharma Group has a short interest ratio ("days to cover") of 71.6, which indicates bearish sentiment.

Change versus previous month

News and Social Media

• Score: 1.0 / 5
• News Sentiment: -0.27

News Sentiment

Mayne Pharma Group has a news sentiment score of -0.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.73 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 8 news articles for Mayne Pharma Group this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Mayne Pharma Group insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 15.80% of the stock of Mayne Pharma Group is held by institutions.

MAYNF Stock Analysis - Frequently Asked Questions

How have MAYNF shares performed this year?

Mayne Pharma Group's stock was trading at $2.79 on January 1st, 2025. Since then, MAYNF stock has increased by 2.2% and is now trading at $2.85.
View the best growth stocks for 2025 here.

When did Mayne Pharma Group's stock split?

Shares of Mayne Pharma Group reverse split on Wednesday, January 18th 2023. The 1-20 reverse split was announced on Wednesday, January 18th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, January 18th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

How do I buy shares of Mayne Pharma Group?

Shares of MAYNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - General
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:MAYNF
• CIK: N/A
• Web: www.maynepharma.com
• Phone: (188) 209-2666
• Fax: N/A
• Employees: 780
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 79.17
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A